r.sobczak
TL2 · Essen
Contributes reviews on supplier material. Based in Essen.
Joined 14 July 2025 · last posted 10d
98Posts here
1Topics
2Solutions
756Likes received
553Likes given
21Badges
191Days visited
3.3kPosts read
Recent activity
Full stream-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #110 · Devices › Syringes & needles · 17 Jul 2026 · 9 likes Coming back to post #108, because the follow-up matters more than the original answer. Dead volume: residual liquid in the hub and needle after withdrawal. Typical…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #86 · Practice › Storage & stability · 11 Jul 2026 · 0 likes Freezing a reconstituted peptide solution is not automatically protective. Freeze-thaw cycling is one of the harsher things you can do to a protein in solution, and a…
-
Prescription requirements and telehealth models — a second dataset Replied, post #86 · Sourcing › Regulatory · 30 Jun 2026 · 6 likes Whatever the answer on Prescription requirements and telehealth models turns out to be, the method for getting there is the same: state the assumption, do the…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 21 Jun 2026 · 0 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
-
Official shortage notices and what they authorise Replied, post #119 · Access › Shortages · 21 Jun 2026 · 4 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Naming conventions for research peptides and the confusion they cause Replied, post #18 · Compounds › Other compounds · 20 Jun 2026 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #4 · Evidence › Preprints · 19 Jun 2026 · 3 likes Adding the measurement that the opening post says would settle it. Adding the boring version of community labels, because the interesting version keeps getting posted…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #49 · Analytics › Method validation · 10 Jun 2026 · 10 likes A definition problem is doing most of the work in this Specificity discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #122 · Practice › Interactions · 9 Jun 2026 · 18 likes Fair, and the limits you put on it are the part I will remember.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #43 · Sourcing › Red flags · 4 Jun 2026 · 33 likes This settles it for me, at least until somebody posts a reason it should not.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #42 · Compounds › Semaglutide · 28 May 2026 · 9 likes Worth separating two things that post #38 runs together. Nobody has said the unglamorous part of semaglutide and gastric emptying yet, so: most of the variation is…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #24 · Pharmacology › Formulation chemistry · 19 May 2026 · 12 likes Trying to state the Solubility limits position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes…